HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anticonvulsant use and outcomes after intracerebral hemorrhage.

AbstractBACKGROUND AND PURPOSE:
There are few data on the effectiveness and side effects of antiepileptic drug therapy after intracerebral hemorrhage. We tested the hypothesis that antiepileptic drug use is associated with more complications and worse outcome after intracerebral hemorrhage.
METHODS:
We prospectively enrolled 98 patients with intracerebral hemorrhage and recorded antiepileptic drug use as either prophylactic or therapeutic along with clinical characteristics. Antiepileptic drug administration and free phenytoin serum levels were retrieved from the electronic medical records. Patients with depressed mental status underwent continuous electroencephalographic monitoring. Outcomes were measured with the National Institutes of Health Stroke Scale and modified Rankin Scale at 14 days or discharge and the modified Rankin Scale at 28 days and 3 months. We constructed logistic regression models for poor outcome at 3 months with a forward conditional model.
RESULTS:
Seven (7%) patients had a clinical seizure, 5 on the day of intracerebral hemorrhage. Phenytoin was associated with more fever (P=0.03), worse National Institutes of Health Stroke Scale at 14 days (23 [9 to 42] versus 11 [4 to 23], P=0.003), and worse modified Rankin Scale at 14 days, 28 days, and 3 months. In a forward conditional logistic regression model, phenytoin prophylaxis was associated with an increased risk of poor outcome (OR, 9.8; 1.4 to 68.6; P=0.02), entering after admission National Institutes of Health Stroke Scale and age. Excluding patients with a seizure did not change the results. Levetiracetam was not associated with demographics, seizures, complications, or outcomes.
CONCLUSIONS:
Phenytoin was associated with more fever and worse outcomes after intracerebral hemorrhage.
AuthorsAndrew M Naidech, Rajeev K Garg, Storm Liebling, Kimberly Levasseur, Micheal P Macken, Stephan U Schuele, H Hunt Batjer
JournalStroke (Stroke) Vol. 40 Issue 12 Pg. 3810-5 (Dec 2009) ISSN: 1524-4628 [Electronic] United States
PMID19797183 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Anticonvulsants
  • Phenytoin
Topics
  • Aged
  • Aged, 80 and over
  • Anticonvulsants (administration & dosage, adverse effects)
  • Cerebral Hemorrhage (drug therapy, epidemiology, surgery)
  • Combined Modality Therapy
  • Craniotomy
  • Epilepsy (drug therapy, epidemiology)
  • Female
  • Fever (epidemiology)
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Phenytoin (administration & dosage, adverse effects)
  • Prospective Studies
  • Recovery of Function
  • Risk Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: